Has submitted its next generation of software and hardware, VMS+4.0, for approval under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. Ventripoint ...
According to recent market research, the global antibiotic susceptibility testing market generated a remarkable USD 3 billion in revenue in 2022 and is on a robust growth trajectory. The market is ...